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A B S T R A C T
To enable selection of novel chemicals for new processes, there is a recognized need for alternative toxicity
screening assays to assess potential risks to man and the environment. For human health hazard assessment these
screening assays need to be translational to humans, have high throughput capability, and from an animal
welfare perspective be harmonized with the principles of the 3Rs (Reduction, Reﬁnement, Replacement).
In the area of toxicology a number of cell culture systems are available but while these have some predictive
value, they are not ideally suited for the prediction of developmental and reproductive toxicology (DART). This
is because they often lack biotransformation capacity, multicellular or multi- organ complexity, for example, the
hypothalamus pituitary gonad (HPG) axis and the complete life cycle of whole organisms.
To try to overcome some of these limitations in this study, we have used Caenorhabditis elegans (nematode)
and Danio rerio embryos (zebraﬁsh) as alternative assays for DART hazard assessment of some candidate che-
micals being considered for a new commercial application. Nematodes exposed to Piperazine and one of the
analogs tested showed a slight delay in development compared to untreated animals but only at high con-
centrations and with Piperazine as the most sensitive compound. Total brood size of the nematodes was also
reduced primarily by Piperazine and one of the analogs. In zebraﬁsh Piperazine and analogs showed develop-
mental delays. Malformations and mortality in individual ﬁsh were also scored. Signiﬁcant malformations were
most sensitively identiﬁed with Piperazine, signiﬁcant mortality was only observed in Piperazine and only at the
higest dose. Thus, Piperazine seemed the most toxic compound for both nematodes and zebraﬁsh.
The results of the nematode and zebraﬁsh studies were in alignment with data obtained from conventional
mammalian toxicity studies indicating that these have potential as developmental toxicity screening systems.
The results of these studies also provided reassurance that none of the Piperazines tested are likely to have any
signiﬁcant developmental and/or reproductive toxicity issues to humans when used in their commercial ap-
plications.
1. Introduction
New products that are brought to the market have to be proven safe
for man and the environment. Hazard assessment of compounds, in
close conjunction with exposure characteristics, are therefore essential
and mandatory requirements. Accepted regulatory toxicity testing for
chemicals currently requires mammalian studies (i.e. rat and rabbit),
which are time- and money-consuming and increasingly considered
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unethical by society. Furthermore, especially when potential hazard for
development and reproduction (DART) is considered, these mammalian
test systems only show low predictive values to man (Sipes et al., 2011).
Proper establishment of alternative testing strategies that are quick, low
cost, ethical and predictive are therefore urgently required to reduce,
reﬁne and replace (3R principle) mammalian testing.
Historically the focus was set on the use of cell culturing systems to
provide promising alternative testing strategies. While these systems
have some beneﬁts (e.g. the possibility of using human cells), these
systems lack the complexity of a complete organism with diﬀerent or-
gans and cell-cell and tissue-tissue signaling, organismal defense me-
chanistic responses towards potential hazardous compounds and as
such have their limitations in possible applicability. There is a need for
lower cost, more rapid, less animal intensive studies to help screen
potential new products to identify those which raise concerns and may
require additional assessment. Such tests could also have value to help
in the deﬁnition of existing product categories under the EU REACH
regulations by either ‘proving’ similar modes of actions and/or identi-
fying products with the highest potential to cause adverse develop-
mental/reproductive eﬀects for longer term animal tests.
Recently two alternative in vivo model systems, Caenorhabditis ele-
gans (nematode) and Danio rerio (zebraﬁsh) which were well known
and used in the ﬁeld of Developmental and Molecular Biology became
noticed as potential promising test systems for hazard assessment (Avila
et al., 2012; Ballatori, 2002; Boyd et al., 2016, 2010; Brannen et al.,
2010; Hermsen et al., 2011; Leung et al., 2008; Panzica-Kelly et al.,
2010; Dhawan et al., 1999; Selderslaghs et al., 2009, 2012). Both spe-
cies share high genetic homology to man (~60% for nematodes and
70% for zebraﬁsh), show cell biologically conserved molecular re-
sponses (like organ development, cell and tissue signaling etc.) and
have proven their translational value (for example, the Nobel prize for
the discovery of apoptosis and miRNAs was rewarded to nematode
researchers (Fire et al., 1998) and both systems are commonly used in
medical research (Ordas et al., 2015; Phillips and Westerﬁeld, 2014;
Poureetezadi and Wingert, 2013; Stewart et al., 2014).
Both nematodes and zebraﬁsh embryos until 5-day post-fertilization
(5dpf) are not considered animals according to relevant animal welfare
acts and regulations. As nematodes and zebraﬁsh are optically trans-
parent small animals with a high reproductive and developmental
turnover they can be considered as an alternative test species for DART
assessment. Because of the high number of progeny each nematode is
able to produce around 250 eggs within 3 days, and one zebraﬁsh an-
imal can produce up to 300 eggs in a week, these organisms have the
potential for high throughput screening. Nematode progeny is fur-
thermore genetically tractable as nematodes are self-fertilizing her-
maphrodites of only 1 mm in size that have shown highly reproducible
predictive developmental timing (Sulston and Horvitz, 1977; Sulston
et al., 1983). Young nematode larvae develop within 3 days to re-
productive hermaphrodites. In zebraﬁsh, development is also rapid as
most organs are formed during early embryo development within
3 days post fertilization. Thus, these systems show high potential to be
properly validated as alternative 3R DART test systems.
In the research project, CRACKIT PreDART funded by the NC3Rs
(UK's national organisation which leads the discovery and application
of new technologies and approaches for 3R purposes), the methodology
for implementation of nematodes and zebraﬁsh as alternative 3R test
models for developmental and reproductive toxicity was set up (pub-
lications in progress). Out of 31 well characterized DART compounds
tested in nematodes and zebraﬁsh, respectively 27 and 23 were prop-
erly predictive for DART. Interestingly, the ones that were missed by
one of the two systems were picked up as DART compounds by the
other system and thus all compounds were scored correctly by combi-
natorial testing using nematodes and zebraﬁsh.
In this study a number of Piperazine analogs for commercial ap-
plication have been evaluated in an experimental screen for re-
productive and developmental toxicity using nematodes and zebraﬁsh
embryos. The screening studies are being evaluated for their potential
to detect developmental toxicity (e.g. intrauterine death including pre-
implantation loss, structural abnormalities, altered growth and func-
tional deﬁcits) while avoiding signiﬁcant use of animals.
In these initial investigations, compounds were tested to assess if the
‘screening’ studies could detect diﬀerences in their potential to cause
developmental/reproductive eﬀects. The amines selected were
Piperazine (CAS: 110-85-0) and the Piperazine analogs A, B and-C.
(PIP-A; PIP-B and PIP-C) One advantage of these substances was that
these are stable and water soluble thereby mitigating any concerns
regarding their exposure to the organisms.
Piperazine has been classiﬁed as a category 2 repro-toxicant under
the EU's Classiﬁcation, Labelling and Packaging (CLP) regulations (EC)
No 1272/2008 and was used as a positive control in the studies de-
scribed, whereas the Piperazine analogs have not been tested and cur-
rently have not been classiﬁed. In rodents Piperazine is a weak class-2
toxicant as it causes embryotoxic eﬀects as resorptions, retardation of
ossiﬁcation, reduced foetal weights and malformations only at high
doses. These eﬀects are considered to be a secondary eﬀect of maternal
toxicity, rather than a direct developmental or reproductive toxicity
eﬀect (Cross et al., 1954; Ridgway, 1987; Risk et al., 2005).
2. Materials &methods
2.1. Materials
Piperazine (95% purity) was obtained from Sigma-Aldrich
(P45907), Piperazine analogs (95% purity) where provided by Shell.
2.2. Nematodes
Nematodes of the N2 strain were synchronized using hypochlorite
and hatched L1 larvae were exposed to the compound that was dis-
solved in nematode growth medium (NGM). L1 larvae were allowed to
develop into adults and subsequently transferred daily to fresh medium.
The range of exposure concentration was the same for all compounds,
i.e. 10−7 M, 10−6 M, 10−5 M, 10−4 M, 10−3 M, 10−2 M. Brood size
was determined by daily passage of adult nematodes onto new plates
and subsequent counting of oﬀspring. The sum of all progeny on all
subsequent wells was used to calculate the total brood size per nema-
tode. Developmental progression was scored by analyzing stage-speciﬁc
parameters (organ development rate) as shown in Fig. 1, Fig. 2, Table 1,
Tables S2 and S3 using the published cell lineage papers (Sulston and
Horvitz, 1977; Sulston et al., 1983). Note: Control populations should
never show any deviation in developmental progression (develop-
mental delay). If they do, experiments are aborted.
Four days before the start of the experiment, nematodes are grown
to bulk quantities on normal food and media (20 times a 5 cm NGM
plate with bacterial OP50 food) to ensure suﬃcient animals to enable
the compound test assay. One day before the start of the experiment
(the start of exposure), these nematode cultures were bleached to
synchronize progeny for the assay. In the absence of food bleaching
results in a synchronous population of L1 staged animals ready for the
test the next day.
On the ﬁrst day of the test (day 0) hatched L1 larvae were placed
onto the NGM agar containing compound and grown at 15 °C for 72 h to
become L4 larvae. Then they were checked under the microscope for
developmental age and morphological eﬀects as listed in Table 1.
Additionally, reproduction eﬀects were scored by exposing 30 in-
dividual L4 animals in three 12 wells plates. For a period of 4 additional
days, these nematodes were transferred each day to a new well leaving
any progeny left on the old plate to grow for one more day before
counting and assessing the viability of the progeny (hatched eggs) and
total brood size.
Proper development of the oﬀspring was assessed by examining
them under a Zeiss Axio Imager M2. The nematode cell lineage is
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completely mapped and development is traceable within precision of
hours using the state of organ development as a reference point in re-
lation to the total developmental time (development of young larvae
only starts when they receive food; t= 0). Both vulva development as
well as gonadogenesis can be scored in L4 larvae to monitor develop-
mental progression. Clear synchronous stages of the developing vulva
can be observed during time, like early divisions of the vulva precursor
cells (VPCs) in L3 stage of development (starting after 29 h at 20 °C),
appearance of the initial vulva cleft (34 h at 20 °C), Christmas tree (40 h
at 20 °C), and vulva lip formation (50 h at 20 °C). In case of develop-
mental delay, all parameters should have the features that are re-
presentative for younger animals than expected according to experi-
mental duration. Because of these easy set of scorable characteristics,
aﬀected development can be monitored in a precise manner and can be
separated from organ speciﬁc eﬀects.
2.3. Zebraﬁsh
Zebraﬁsh experimental procedures were conducted in accordance
with local and international regulations and followed the guidelines on
the protection of experimental animals by the Council of Europe,
Directive 2010/63/EU reduction, replacement and reﬁnement strategy.
Zebraﬁsh were handled and maintained according to standard protocols
(“The Zebraﬁsh Model Organism Database,” ZFIN www.zﬁn.org).
Zebraﬁsh larvae were collected from laboratory cultures. All tests were
undertaken at 28 °C under a 14 h:10 h dark-light cycle. Controls and
tests solutions were prepared in ‘egg water’ (60 μg/ml Instant Ocean™
sea salt, Sera Marin in distilled water). Individual larvae were raised in
a separate well in a 24 well polypropylene plates containing 2 ml of the
test substance (10−7 M, 10−6 M, 10−5 M, 10−4 M, 10−3 M, 10−2 M).
Larvae were exposed in the static way. For phenotypic observation
bright-ﬁeld, Leica M165C stereomicroscope was used at various mag-
niﬁcation (2×-16×) equipped with a DFC420C digital colour camera
(Leica Microsystems).
20 newly fertilized zebraﬁsh eggs were selected per replicate, be-
tween 2 and 64 cell stage (before blastulation) and exposed to test
chemicals for a period of 96 h. The development of the embryos was
followed on a daily basis. After 96 h, lethality was assessed on the basis
of either/or: (I) coagulation of fertilized eggs, (II) lack of somite for-
mation, (III) lack of heartbeat. At the end of the 96 h exposure period,
ﬁsh larvae behavior in response to mechanical stimuli and phenotypic
changes were recorded. Unresponsive behavior of the test is indicative
of abnormal development or destruction of the nervous system and/or
abnormality of the muscle contraction. Phenotypic examinations were
undertaken on 20 larvae per concentration using relevant endpoints
identiﬁed during the NC3R Crack it PREDART project (Table 1 and
Table S4). The procedure was performed in duplicate. 10% deviation
from zero incidents was accepted for the internal control ﬁsh (4 per 24
well plate) similarly to what has been agreed as acceptable in the Fish
Embryo Acute Toxicity (FET) Test (OECD/OCDE 236). The phenotypic
assessments, which were considered to be indicative of teratogenicity,
included observation of abnormalities in organ development (Table 1).
Acute toxicity (lethality) and delayed development were also scored on
day 4 post fertilization. Spontaneous incidents in the untreated control
group were scored as well. In the case of low occurrence (< 10%) in the
experiment, the results were normalized to the untreated control group
and the score of the spontaneous events were subtracted from the re-
sult. In the case of higher percentage of spontaneous death or mal-
formation in the control group (> 10%), the test became invalid and
was discarded. Characterization of normal development of the embryo
was followed in the untreated control group and was identiﬁed based
on the standard developmental timeline (Kimmel et al., 1995). Devel-
opmental delay was based on three main phenotypic appearances:
head-trunk angle, tail length and occurrence of the swim bladder. When
eﬀects in at least two characteristics were scored, this was indicated as
developmental delay. Note: delayed development might be a secondary
eﬀect of abnormal organ development and conclusions regarding de-
velopmental delay should, therefore, be treated with caution.
3. Results & discussion
Nematodes and zebraﬁsh larvae were exposed to a range of con-
centrations of Piperazine and three Piperazine analogs. Developmental
eﬀects were scored by analyzing organ development and a set of other
parameters (see Table 1 and Tables S2 and S4).
No chemical analysis was undertaken to assess exposure con-
centrations. However, based on their physicochemical properties, in-
cluding water solubility, all the compounds are expected to be soluble
and well absorbed (Lipinski, 2004). Furthermore, as Piperazine appears
to be well absorbed (with peak plasma concentrations attained 1 h after
oral administration according to the REACH dossier), it can be assumed
that nematodes and zebraﬁsh have been exposed signiﬁcantly sys-
temically.
Nematodes exposed to Piperazine and PIP-A, showed a slight delay
in development compared to untreated animals but only at high
Fig. 1. Phenotypic eﬀects in nematodes and zebraﬁsh exposed to Piperazine reveal mild
eﬀects in development.
Nematodes and zebraﬁsh both show a mild developmental delay when exposed to high
concentrations of Piperazine. While 100% of the nematode larvae developed to L4 stage
in the control after 25 h exposure at 20 °C (A), 10−2 M Piperazine exposure revealed 71%
L3 and 29% L2 stage animals (B) (also shown in Table S2). Fig. B shows an L3 stage
animal. The arrow in A indicates the vulva, a developmental marking point of L4 stage.
Scalebar: 100 μm. Panel C and D show zebraﬁsh embryos and show delayed zebraﬁsh
development (D) compared to the control (C). In zebraﬁsh in 60% of the cases the swim
bladder appeared undeveloped at 4dpf after Piperazine exposure, indicative for devel-
opmental delay eﬀects (position of swim bladder is indicated by an arrow). Also tail
length and head-trunk angle are aﬀected in the animal in D and are indicative for de-
velopmental delay.
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concentrations (starting at 10−4 M and 10−2 M, respectively), whereas
PIP-B and PIP-C did not show any delay eﬀects (Figs. 1 and 2 and Table
S2). Total brood size of the nematodes was also reduced when exposed
to Piperazine and PIP-A at 10−6 M and higher, for PIP-B and PIP-C at
10−5 M and higher (Fig. 2B and Table S3). There was no eﬀect on
larval mortality in nematodes after any of the treatments.
In zebraﬁsh an increased dose of Piperazine and analogs indicated
an increase in the percentage of ﬁsh with developmental delay.
Fig. 2. Only high concentrations of Piperazines aﬀect developmental rate and reproduction in nematodes and zebraﬁsh.
The four top panel graphs indicate developmental delay in nematodes and zebraﬁsh after exposure to diﬀerent concentrations of Piperazines (Piperazine, PIP-A, PIP-B and PIP-C).
Nematode bars are in light grey, zebraﬁsh bars in black. PIP-B and PIP-C do not cause any developmental delay in nematodes while Piperazine at high concentrations causes the strongest
developmental delay. Only a trend could be scored in Piperazine and PIP-C in zebraﬁsh as unlike the eﬀects in nematodes, developmental delay could be caused by a range of secondary
eﬀects like: acute toxicity, organ malformation and eﬀects on the rate of development. All plotted samples are normalized against the control. As the test criteria for valid nematode tests
is that control nematodes always develop according to a ﬁxed time schedule (without variation), all light grey bars represent therefore the deviation from the control (A). The lower four
panels show the average number of oﬀspring per nematode hermaphrodite larvae after exposure to the diﬀerent Piperazine analogs. Only high concentrations of Piperazine analogs cause
eﬀects on the number of oﬀspring. Piperazine and PIP-A show the strongest eﬀects. Signiﬁcance was determined by an unpaired t-test with 95% conﬁdence interval (*p < 0,05;
**p < 0,01, ***p < 0,001) (B). Error bars are indicating the standard error (standard deviation/√n).
Table 1
Scoring table of potentially aﬀected organ development & reproduction.
A broad range of developmental and reproductive eﬀects were scored after Piperazine exposure in nematodes and zebraﬁsh. Both species were only mildly aﬀected by the Piperazines.
The percentage of the aﬀected organisms at the highest test concentration (10−2 M) are indicated in the table for the individual compounds. All data is normalized to the control. Brood
size in nematodes was signiﬁcantly aﬀected. Only the hemorrhage that was observed in PIP-A appeared to be signiﬁcant in zebraﬁsh. Signiﬁcance values are indicated as followed:< 0.05
(*), < 0.01 (**) and< 0.001 (***). The number of incidences and statistics can be found in Tables S2, S3, S4 and S5.
Organism Phenotype Eﬀect Aﬀected organisms (%) at highest test concentration (10−2 M)
Piperazine PIP-A PIP-B PIP-C
N Reproductive organs (gonad,
vulva)
Organisation, shape, size and absence of the organs;
multi vulva
0 0 0 0
N Nervous system Movement, egg laying, behavoir 0 0 0 0
N Intestine Organisation, shape, size and presence of the organs 0 0 0 0
N Cuticle Molting problems, protruding/burst through vulva,
dumpy, blistered
0 0 0 0
N Muscles Movement, egg laying, uncoordinated movements 0 0 0 0
ZF Fin 0 0 0 0
ZF Heart Acardia - absence of heart 0 0 0 0
Pericardial oedema 7.5 10.0 2.5 0
Tube heart formation (heart has no chamber) 0 0 0 0
Cardiac enlargement 0 0 0 0
ZF Brain (head) Brachycephalic (short broad head) 0 0 0 0
Dolichocephalic (long narrow head) 0 0 0 0
Reduced development the nose and the jaw 0 0 5 0
ZF Spine Bent tail, bent head-trunk angle 0 0 2.5 2.5
ZF Eye Cyclopia (one eye) 0 0 0 0
Eye oedema 0 0 0 0
N Clear Often correlated to defects in FGF signaling pathway 0 0 0 0
N Chromosomal instability High incidence of males 0 0 0 0
N Variably abnormal Often correlated with cell-cell contact problems in
epithelial cells
0 0 0 0
N Size Often correlated with cell division problems 0 0 0 0
N Reduced number of progeny Percentage 35.1*** 65.7*** 14.6*** 19.3**
N Dauers Often correlated with problems in metabolism or eating
problems
0 0 0 0
ZF Hemorrhage Blood collection in abnormal places 0 10*** 2.5 2.5
ZF Larvae movement Partial hatch/no reaction to touch stimulus 0 0 0 0
ZF Excessive opercular movement (Absence of oxygen) 0 0 0 0
ZF Abnormal hatching 0 0 2.5 0
ZF Pigment formation Abnormal pattern 2.5 2.5 0 0
Absence of pigmentation 0 0 0 0
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Developmental delay could occur as secondary eﬀects of malformations
or acute toxicity and thus possibly represents an accumulative eﬀect.
Malformations in individual ﬁsh were therefore also scored (Fig. 3
and Table S4). A signiﬁcant number of ﬁsh with malformations could be
seen at Piperazine concentrations of 10−6 M. Yet, a huge increase in the
number of incidences took only place at higher concentrations in all
analogs (Fig. 3, Table S4, Table S5). PIP-A and PIP-B required an even
1000× higher dose before malformations were statistically relevant.
Thus, Piperazine seemed the most toxic compound in zebraﬁsh with
only high increase in incidence numbers at high dose.
None of the tested compounds showed eﬀects on heart function in
zebraﬁsh (bradycardia, tachycardia and arrhythmia). In addition, there
was no indication of neurological functional defects as all of the ex-
posed zebraﬁsh larvae, even in the highest concentrations, responded to
the touch stimulus test (Table 1, data not shown). A very weak eﬀect
was found when mortality was assessed in the highest concentration of
Piperazine (Table S1).
In summary, from the Piperazines tested in the current study,
Piperazine itself was the most potent toxicant to induce both re-
production toxicity and developmental delay in nematodes and mal-
formations and mortality in zebraﬁsh. Piperazine and PIP-A showed the
highest sensitivity in aﬀecting brood size in nematodes (10−6 M).
These results are in alignment with the reported test data for rats and
rabbits on Piperazine, where indications of reproductive eﬀects were
observed at high test concentrations (Cross et al., 1954; Ridgway, 1987;
Risk et al., 2005). Furthermore, the observed responses are considered
to be a consequence of maternal toxicity rather than a direct develop-
mental or reproductive eﬀect per se. Therefore, based on all of the
above it is concluded that the Piperazine analogs tested are unlikely to
be developmental toxicants.
An important consideration from the outset was the speed and cost
of the alternatives in comparison to longer term ‘traditional’ DART
studies. The tests have been compared in Table 2.
These data demonstrates that in comparison to the conventional
DART studies the alternative methods are rapid, far less time con-
suming and could signiﬁcantly reduce animal use. At the moment ne-
matodes and zebraﬁsh tests are not yet suitable to make translational
statements on eﬀective concentration levels in higher systems nor in
other aspects of risk assessment. This study indicates however that
there is a relevance to use these assays as alternative screening tests to
identify potential developmental and reproductive toxicity eﬀects of
compounds early in the product developmental pipeline.
Further evidence of the value of these assays comes from NC3Rs
CrackIT PREDART challenge project in which a DART hazard assess-
ment of a whole group of 31 well-known positives was analyzed using
Dictyostelium discoideum (slime mould), nematodes and zebraﬁsh em-
bryos. For a selected group of compounds, the molecular response of
the three diﬀerent species were assessed using RNAseq analyses.
Despite the fact that diﬀerent phenotypic outcomes were observed, the
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Fig. 3. The number of aﬀected zebraﬁsh embryos upon
treatment with Piperazine and its analogos.
Malformation occurrence was registered based on a
CrackIT scoring table (y-axis represents the number of
aﬀected embryos). The bars represent the mean and
standard deviation of the experiments (n = 2 experi-
ments). The malformation occurrence was normalized to
controls, and acute toxicity eﬀects were corrected. A
signiﬁcant number of ﬁsh with malformations can be
observed at Piperazine concentrations of 10−6 M. The
number of incidences increases at higher concentrations
in all analogs (see also Tables S4 and S5). Statistical va-
lues were calculated with an unpaired t-test with 95%
conﬁdence interval (*p < 0,05; **p < 0,01,
***p < 0,001).
Table 2
Overview of diﬀerent test methodologies for assessment of developmental and re-
production toxicity.
Golden standard OECD protocols are compared with 3R nematodes and zebraﬁsh test
models. These latter two models show that testing is fast, low cost and 3R proof.
Nematode Zebraﬁsh OECD 414 OECD 416/
443
Indicative cost Low Low Moderate High
Study duration 1 week 1 week 3 weeksb 30 weeksb/
21 weeksb
Exposure Buﬀer Water Gavage Gavage
3Rs issues None Vertebrate Rats & rabbits Rats
Number of
animals used
None None (until
5dpf)
~900 rats,
~500 rabbits
~2600/
1400a rats
Regulatory
acceptability
No (screen
WoE)
No (screen
WoE)
Yes Yes
a Basic design, i.e. no cohorts and extension to F2.
b In-life portion of the study.
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toxicogenomic proﬁle identiﬁed potential molecular mechanisms with
human relevance and was shared across the test species (https://www.
nc3rs.org.uk/integrative-dictyostelium-c-elegans-and-zebraﬁsh-
approach-assess-dart, manuscripts in prep).
4. Conclusions
The fact that the results of the nematodes and zebraﬁsh assays are in
alignment with data obtained from mammalian toxicity studies indicate
that these have potential as developmental and reproductive toxicity
screens without the need to use signiﬁcant numbers of animals. The
results of these studies also provide indication that none of the
Piperazine analogs tested are likely to have any signiﬁcant develop-
mental issues to humans when used in commercial applications.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.tiv.2017.06.002.
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